pimavanserin

Related by string. Pimavanserin * * commercialize pimavanserin . pimavanserin ACADIA *

Related by context. All words. (Click for frequent words.) 72 Pimavanserin 69 Parkinson disease psychosis 64 bicifadine 62 lurasidone 61 safinamide 61 PRX # 61 daclizumab 60 Acadia Pharmaceuticals 60 Lu AA# 60 alvimopan 60 ularitide 60 ocrelizumab 60 betrixaban 60 asenapine 60 Corlux 60 Lupuzor 60 Serdaxin 59 phase IIb 59 ACADIA 59 otelixizumab 59 Relovair 59 tezampanel 59 almorexant 58 elotuzumab 58 tasimelteon 58 phase IIb clinical 58 iloperidone 58 JAK inhibitor 58 phase IIb trial 58 ProSavin 58 dirucotide 58 Clonicel 58 Sulonex 58 phase IIa clinical 58 bifeprunox 58 commercialize pimavanserin 58 metaglidasen 58 dimebon 57 Mipomersen 57 adipiplon 57 iniparib 57 darusentan 57 Plicera 57 pradefovir 57 placebo controlled clinical 57 deforolimus 57 methylnaltrexone 57 Targretin 57 Synavive 57 mipomersen 57 XL# XL# XL# XL# 57 gaboxadol 57 bapineuzumab 57 PEG PAL 57 DR Cysteamine 57 KRN# 57 aflibercept 57 Phase IIa clinical 57 Oral NKTR 57 picoplatin 56 Canvaxin 56 Phase 2b study 56 TBC# 56 milnacipran 56 Asentar 56 Durect 56 cannabinor 56 cangrelor 56 NUVIGIL 56 L BLP# 56 Azedra TM 56 midstage studies 56 valopicitabine 56 lixivaptan 56 Indiplon 56 midstage clinical 56 dacetuzumab 56 Bicifadine 56 midstage clinical trial 56 apremilast 56 solanezumab 56 SinuNase 56 desvenlafaxine 56 Dacogen injection 56 Phase IIa trial 56 Memryte 56 bosutinib 56 volociximab 56 Cinquil 56 Serdolect 56 regadenoson 56 Archexin 56 celgosivir 56 selective androgen receptor modulator 56 AEGR 56 linaclotide 55 telcagepant 55 Aurexis 55 Technosphere Insulin 55 RG# [001] 55 IPL# 55 glufosfamide 55 Amigal 55 taspoglutide 55 Phase 2a trial 55 lumiliximab 55 HGS# 55 Ostarine 55 Phase 2b clinical 55 Milnacipran 55 alvespimycin 55 bardoxolone 55 Phase IIb trials 55 allosteric modulator PAM 55 Alzheimer disease psychosis 55 INCB# [002] 55 LymphoStat B 55 secondary efficacy endpoints 55 HuMax CD# 55 ostarine 55 Gralise 55 active comparator 55 Neurodex 55 NNR Therapeutics 55 Phase 1b trial 55 Panzem R NCD 55 TRAIL receptor antibodies 55 DPP4 inhibitor 55 orBec 55 GALNS 55 Phase Ib 55 BCX# 55 ponatinib 55 Amrubicin 55 Santhera 55 custirsen 55 TELINTRA 55 Ereska 55 vicriviroc 55 Phase IIb clinical 55 danoprevir 55 mGluR2 positive 55 Prestara 55 Insegia 55 ELND# 55 dimebon latrepirdine 55 dirucotide MBP# 55 vosaroxin 55 cetrorelix 55 Safinamide 55 PDE# inhibitors 55 Genentech Roche 54 Æterna Zentaris 54 Ziopharm 54 atrasentan 54 CDP# 54 regorafenib 54 Traficet EN 54 Ambrisentan 54 IRX 2 54 Solzira 54 PD LID 54 vernakalant oral 54 INCB# [001] 54 ALKS 54 Alzhemed TM 54 tanespimycin 54 lintuzumab SGN 54 class mGluR5 inhibitor 54 Abilify aripiprazole 54 elagolix 54 Rebif ® 54 Phase Ib study 54 SILENOR 54 Phenoptin 54 Phase 2b trial 54 Desmoteplase 54 Phase IIa clinical trials 54 diabetic neuropathic pain 54 febuxostat 54 indiplon 54 Rezular 54 ocular formulation 54 PRT# 54 KNS # 54 PDE4 inhibitor 54 Pharmasset 54 Tavocept 54 Itopride 54 Viprinex 54 ridaforolimus 54 sapacitabine 54 teriflunomide 54 lorvotuzumab mertansine 54 mapatumumab 54 Phase 2a 54 ambrisentan 54 CORLUX 54 Lung Rx 54 Vilazodone 54 taribavirin 54 oral cladribine 54 Phase III clinical 54 albinterferon alfa 2b 54 agomelatine 54 PEG Interferon lambda 54 muraglitazar 54 atacicept 54 Biogen Idec BIIB 54 glucokinase activator 54 CR# vcMMAE 54 Estorra 54 Tolerx 54 MDV# 54 JP-#/fipamezole 54 baminercept 54 HuMax CD4 54 Phase III trials 54 Zenvia ™ 54 CYCLOSET 54 Valdoxan 54 voclosporin 54 frovatriptan 54 Ranexa 54 cognitive impairment associated 54 ibudilast 54 OHR/AVR# 54 rilpivirine 54 DPX Survivac 54 Troxatyl 54 Phase 2a clinical 54 ISIS # 54 KRYSTEXXA TM pegloticase 54 XmAb# 54 Seattle Genetics SGEN 54 BRAF inhibitor 54 ASA# 54 tecarfarin 53 Entereg R 53 Unit Dose Budesonide 53 dexanabinol 53 MNTX 53 PEG SN# 53 sunitinib malate 53 Ixempra 53 6R BH4 53 phase IIa 53 Zybrestat 53 CRx 53 SAR# [004] 53 MACUGEN 53 clazosentan 53 dexpramipexole 53 GED aPC 53 lintuzumab 53 fesoterodine 53 Kyowa Hakko Kirin 53 HepeX B 53 NV1FGF 53 Bifeprunox 53 aplindore 53 Shigamabs ® 53 R#/MEM 53 MAP# 53 ataluren 53 ulimorelin 53 axitinib 53 palonosetron 53 SUCCEED trial 53 OMAPRO 53 Zoraxel 53 registrational trial 53 refractory gout 53 faropenem 53 motesanib 53 bardoxolone methyl 53 Phase 2b clinical trials 53 Oglemilast 53 ozarelix 53 Campath ® 53 Alexza 53 NLX P# 53 Levadex 53 RGB # 53 HuLuc# 53 pertuzumab 53 davunetide 53 Nuvion 53 Cetrorelix 53 Phase #b/#a 53 zileuton 53 PF # [001] 53 Dimebon 53 paliperidone ER 53 REMOXY ® 53 Corcept 53 Adentri 53 vernakalant 53 R#/MEM # 53 PHX# 53 APEX PD 53 incyclinide 53 OvaRex R 53 NVA# 53 EVIZON 53 LAF# 53 Empatic 53 lixisenatide 53 Relivar 53 Fablyn 53 Telcyta 53 canagliflozin 53 ONTAK 53 severe hypercholesterolemia 53 Androxal TM 53 alemtuzumab Campath 53 orally inhaled migraine 53 enzastaurin 53 Apoptone 53 Factor VIIa 53 Zalbin 53 sNDA submission 53 mixed dyslipidemia 53 Incyte 53 cladribine tablets 53 Acapodene 53 XenoPort 53 Fibrillex TM 53 Idenix 53 experimental hepatitis C 53 pagoclone 53 Phase #/#a 53 Exelixis 53 GVAX 53 Nasulin 53 Starlix 53 FOLOTYN ® 53 efficacy tolerability 53 ARIKACE ™ 53 elinogrel 52 atypical antipsychotic 52 Allovectin 7 52 BEMA TM Fentanyl 52 Virulizin ® 52 rindopepimut 52 subcutaneous formulation 52 Syntonix 52 MoxDuo IR 52 velafermin 52 Ocrelizumab 52 Huntexil 52 NASDAQ REGN 52 commercialize XL# 52 AEG# 52 OGeS 52 davunetide intranasal AL 52 Tasimelteon 52 Phase 2b 52 gepirone ER 52 EDEMA3 52 sodium oxybate 52 ixabepilone 52 midstage clinical trials 52 Lurasidone 52 NP2 Enkephalin 52 RSD# oral 52 Xcytrin R 52 tenofovir emtricitabine 52 Bristol Myers Squibb BMY 52 Gattex 52 QuatRx 52 Exelixis EXEL 52 opioid induced bowel dysfunction 52 OncoVEX GM CSF 52 rNAPc2 52 Dynogen 52 HQK 52 Fanapt iloperidone 52 Arcalyst 52 bazedoxifene 52 Reverset 52 ELADUR 52 Aflibercept 52 Syncria 52 APD# 52 tezampanel NGX# 52 mGluR5 PAM 52 retigabine 52 Trexima 52 symptomatic neurogenic orthostatic hypotension 52 brentuximab vedotin 52 Gabapentin GR 52 pomalidomide 52 Ketotransdel 52 AGILECT R 52 Progenics Pharmaceuticals 52 Nuvigil 52 GLPG# 52 eniluracil 52 PF # [002] 52 SNT MC# 52 OvaRex ® MAb 52 BNC# 52 LymphoStat B belimumab 52 NEVO ™ 52 TOCOSOL Paclitaxel 52 Horizant 52 exenatide LAR 52 oxymorphone ER 52 reslizumab 52 Vernakalant 52 vemurafenib 52 oral prodrug 52 teplizumab 52 REMINYL ® 52 Kosan dependence 52 RLY# 52 Chrysalin 52 Prednisporin TM 52 MEK inhibitors 52 HCV protease inhibitors 52 Qnexa 52 enoximone 52 tolvaptan 52 Contrave# 52 ruxolitinib 52 Onalta 52 Saphris 52 canakinumab 52 schizophrenia CIAS 52 AUXL 52 cediranib 52 Sanctura XR 52 rolofylline 52 TriLipix 52 Medivation 52 Saxagliptin 52 Catena ® 52 Pruvel 52 ABII 52 antiplatelet agent 52 alfimeprase 52 vilazodone 52 Stimuvax R 52 Nexavar sorafenib 52 ALTU 52 RhuDex ® 52 Flurizan 52 ruboxistaurin 52 Sanctura 52 SARMs 52 forodesine 52 virus HCV protease inhibitor 52 ZYBRESTAT 52 ZYBRESTAT fosbretabulin 52 Cypress Bioscience 52 Veronate 52 alogliptin 52 interferon gamma 1b 52 fidaxomicin 51 ICA # 51 AstraZeneca Seroquel 51 Antegren 51 visilizumab 51 Asenapine 51 golimumab 51 LibiGel ® 51 taranabant 51 obatoclax 51 blinatumomab 51 treprostinil 51 RSD# 51 tolevamer 51 relapsing remitting multiple sclerosis 51 Tocosol Paclitaxel 51 ganetespib 51 Iluvien ® 51 faropenem medoxomil 51 Darusentan 51 aleglitazar 51 MAXY alpha 51 irbesartan 51 midstage study 51 investigational atypical antipsychotic 51 amrubicin 51 PREOS R 51 PXD# 51 YONDELIS R 51 HCV protease inhibitor 51 PsychoGenics 51 Iloperidone 51 Phase III clinical trials 51 TELCYTA 51 Revlimid lenalidomide 51 Theratope 51 opioid bowel dysfunction 51 Transition Therapeutics 51 Xenoport Inc. 51 Herceptin trastuzumab 51 blood clot preventer 51 panitumumab 51 trastuzumab DM1 51 Treanda 51 AVE# 51 Sunesis Pharmaceuticals 51 YONDELIS 51 Dificid 51 CoFactor 51 BioMS 51 GSK# [002] 51 Targacept 51 Addex 51 Tolvaptan 51 eprotirome 51 Erbitux 51 oral ridaforolimus 51 PSN# [002] 51 Dapagliflozin 51 ZYFLO CR 51 pramlintide 51 Folotyn 51 Daclizumab 51 Icatibant 51 Vivus Qnexa 51 Intermezzo R 51 Acetavance 51 candidate XP# 51 Laquinimod 51 Genentech Rituxan 51 Xenoport 51 Civacir 51 Oxytrex 51 Puricase 51 OXi# 51 Dicer Substrate Technology 51 Adventrx 51 Proteolix 51 Azixa 51 Exelixis compounds 51 Nanobody 51 desvenlafaxine succinate 51 CaPre TM 51 AERx iDMS 51 Viramidine 51 romazarit 51 Sycrest 51 pegloticase 51 Abbott ABT 51 R sorafenib tablets 51 Telaprevir 51 Archemix 51 Adolor 51 Prednisporin 51 cortical stimulation 51 angioedema indications 51 NASDAQ ISIS 51 zileuton CR 51 phase 2a 51 Avanir 51 IV APAP 51 GRN# 51 Regeneron Pharma 51 arzoxifene 51 Cerovive 51 CoTherix 51 Firazyr 51 pramipexole 51 Ception 51 PS# [001] 51 vidofludimus 51 Vertex VRTX 51 Flutiform TM 51 Soliris TM eculizumab 51 Ceflatonin 51 ImClone Erbitux 51 tiapamil 51 ospemifene 51 perampanel 51 Omigard 51 AcelRx 51 neurogenic orthostatic hypotension 51 tonabersat 51 MBP# [001] 51 TRACON Pharmaceuticals 51 Oxigene 51 darunavir 51 CCR5 antagonist 51 TriRima 51 Proquin XR 51 J. Donald deBethizy 51 Inflazyme 51 EndoTAG TM -1 51 Intarcia 51 Serdolect ® 51 oral FTY# 51 Ceregene 51 Phase IIB 51 AZD# 51 Immunogen 51 perifosine 51 BEMA Buprenorphine 51 CINQUIL 51 outlicensing 51 Mpex 51 JZP 6 51 Vectibix panitumumab 51 ramelteon 51 Ardea Biosciences 51 Mr. Bentsur 51 Kuvan 51 PEG INTRON 51 Nanobody ® 51 peginesatide 51 Medidur FA 51 lomitapide 51 Alzhemed 51 Fibrillex 51 carfilzomib 51 Fanapt 50 NKTR 50 XL# [003] 50 fingolimod 50 E2F Decoy 50 phase IIb study 50 HZT 50 Vaccinex 50 tremelimumab 50 cathepsin K inhibitor 50 Balaglitazone 50 lorcaserin 50 BAY #-# 50 FOLOTYN 50 olanzapine Zyprexa 50 Hematide 50 Trizytek 50 gabapentin enacarbil 50 CA4P 50 BRIM2 50 immunomodulatory therapy 50 Fx #A 50 CIMZIA ™ 50 HGS ETR2 50 tipranavir 50 Neurocrine 50 afatinib 50 darapladib 50 telbivudine 50 ProLindac 50 registrational 50 TroVax 50 Panitumumab 50 confirmatory Phase 3 50 tasocitinib 50 Focalin XR 50 Miraxion 50 Genz # 50 risperidone Risperdal 50 clofarabine 50 Trofex TM 50 investigational therapies 50 zanolimumab 50 Entereg 50 Serada 50 Sygnis 50 Spiegelmer ® 50 iSONEP 50 INCB# [003] 50 ACTEMRA 50 FoldRx 50 AEterna 50 Fampridine SR 50 Zemiva TM 50 AZILECT R 50 CB1 antagonists 50 zibotentan 50 CoMentis 50 eltrombopag 50 TRANSDUR Sufentanil 50 Carfilzomib 50 trospium 50 senicapoc 50 Prochymal 50 bendamustine 50 Ph.D. Targacept 50 MabThera rituximab 50 RezularTM 50 leading oral taxane 50 Optiquel ™ 50 aptamer therapeutics 50 Accolate 50 Incyte Corp 50 Immunomedics 50 tamibarotene 50 TOCOSOL Camptothecin 50 Sucampo 50 PROSTVAC TM 50 rufinamide 50 dapagliflozin 50 huC# DM4 50 ASG 5ME 50 refractory CLL 50 AEterna Zentaris 50 pralatrexate 50 TTHI 50 telaprevir 50 ATryn R 50 Dyloject TM 50 RSR# 50 DEB# 50 Cladribine Tablets 50 Nasdaq ACAD 50 Ligand 50 Dynavax 50 Major Depressive Disorder MDD 50 selective androgen receptor modulators 50 LY# [003] 50 ATL# [001] 50 Remicade infliximab 50 OMNARIS HFA 50 Medivation Inc 50 compound INCB# 50 LEVADEX 50 AP# [003] 50 BRIM3 50 Uplyso 50 sertraline Zoloft 50 Symadex 50 Avanafil 50 Zelrix 50 Alkermes ALKS 50 Atherogenics 50 SYGNIS 50 Phase IIb clinical trials 50 Dacogen 50 GSK# [001] 50 Naproxcinod 50 PhosLo 50 nicotinic alpha 7 50 Sigma Tau SpA 50 nabilone 50 Gemin X 50 Simdax 50 MOGN 50 Galenea 50 Auxilium Pharmaceuticals 50 Promacta 50 Diamyd ® 50 romidepsin 50 Auxilium Pharma 50 Raptiva ® 50 lasofoxifene 50 randomized Phase 2b 50 ZOLINZA 50 investigational drug 50 Targeted Chemotherapy 50 unoprostone isopropyl 50 Isis Pharmaceuticals ISIS 50 saxagliptin 50 HuMax EGFr 50 Curagen 50 Nasdaq BIIB 50 Ventavis 50 EOquin 50 Glufosfamide 49 Silenor ® doxepin 49 clinical trials dacetuzumab SGN 49 torezolid phosphate 49 Vertex telaprevir 49 CIMZIA TM 49 QNEXA 49 pivotal Phase III 49 Addrenex 49 Corgentech 49 Zavesca r 49 Aryplase 49 vascular disrupting agent 49 oral rivaroxaban 49 novel oral anticoagulant 49 generation proteasome inhibitor 49 Axonyx 49 Hyphanox 49 oxypurinol 49 pseudobulbar affect PBA 49 CANCIDAS 49 Parkinson disease levodopa induced 49 Golimumab 49 cetuximab Erbitux 49 davalintide 49 S/GSK# 49 sitaxsentan 49 preclinical 49 IMC #F# 49 Penwest Pharmaceuticals 49 Dyax phage display 49 Xinlay 49 viral kinetic 49 Ariad Pharmaceuticals Inc. 49 immuno inflammatory diseases 49 Aegera 49 Vicriviroc 49 Satraplatin 49 Harbor BioSciences 49 sipuleucel T 49 fidaxomicin Phase 3 49 #D#C# 49 NATRECOR R 49 alemtuzumab 49 donepezil Aricept 49 targeted radiotherapeutic 49 laquinimod 49 Orazol 49 Orencia abatacept 49 Frova ® 49 Allovectin 7 R 49 aclidinium 49 Zerenex 49 sargramostim 49 mirtazapine 49 Humira adalimumab 49 PROMACTA 49 Ceflatonin R 49 Ramoplanin 49 DU #b 49 IMA# 49 constipation predominant irritable bowel 49 InNexus Biotechnology 49 oral methylnaltrexone 49 GEM OS2 49 Arqule 49 IMGN 49 Solasia 49 Behcet uveitis 49 ThGRF 49 abiraterone 49 Idera Pharmaceuticals 49 MAP Pharmaceuticals 49 Albuferon 49 riociguat 49 GENR 49 satraplatin 49 figitumumab 49 Benlysta belimumab 49 lupus nephritis 49 Adlea 49 Celgene Revlimid 49 Phase #/#a clinical 49 Ticagrelor 49 Increlex ® 49 Sprycel 49 Mannkind 49 fostamatinib 49 UPLYSO 49 Phase III 49 opioid induced 49 carcinoid syndrome 49 Prosaptide 49 Anacor 49 Telintra 49 Sanvar 49 IIa trial 49 Synta 49 pharmacological chaperone 49 nalbuphine ER 49 aldehyde dehydrogenase ALDH2 deficiency 49 Amplimexon 49 Vertex Pharmaceuticals NASDAQ VRTX 49 Hedgehog antagonist 49 Vertex Pharma 49 SILENOR TM 49 Factor Xa inhibitor 49 novel trazodone formulation 49 prokinetic agent 49 Molecular Insight 49 MYDICAR 49 Exelixis Nasdaq EXEL 49 NeuroSearch 49 URG# 49 MAXY VII 49 hepatitis C protease inhibitor 49 Targretin capsules 49 ONCONASE R 49 maribavir 49 Sym# 49 Zalicus 49 Opexa 49 abatacept 49 Coreg CR 49 Xanafide 49 ITAX 49 Biogen Idec 49 generation purine nucleoside 49 Xyotax 49 Numax 49 exenatide once 49 Octreolin 49 aripiprazole Abilify 49 Salmedix 49 Wellstat 49 Campath alemtuzumab 49 Fodosine 49 atypical antipsychotics 49 diarrhea predominant irritable 49 Amgen Enbrel 49 Aryx 49 Metabasis 49 Ophena TM 49 Ophthotech 49 ATL/TV# 49 Vectibix 49 TACI Ig 49 Triolex 49 CTAP# Capsules 49 placebo controlled studies 49 ACTEMRA TM 49 therapeutic modalities 49 brivaracetam 49 zalutumumab 49 KALBITOR 49 DSMB 49 Somaxon Pharmaceuticals 49 Akt inhibitor 49 dose cohorts 49 TREANDA 49 Tekamlo 49 Proxinium TM 49 Alzheimer disease cognitive impairment 49 Q#IR 49 Amylin AMLN 49 T DM1 49 Celladon Corporation 49 oral salmon calcitonin 49 Indaflex TM 49 preclinically 49 dyskinesia PD LID 49 SAPHRIS 49 DepoMed 49 nebivolol 49 Oncogenex 49 investigational compounds 49 bipolar depression 49 Eli Lilly Cymbalta 49 StromaCel Inc. 49 Torisel 49 Eli Lilly LLY 49 ezogabine 49 etanercept Enbrel 49 Myrexis 49 PRIMO CABG 49 Titan Pharmaceuticals 49 Potiga 49 Celator 49 COMT inhibitors 49 Imagify 49 Biogen Idec NASDAQ BIIB 49 Receptos 49 Phase Ib II 49 maximally tolerated dose 49 rasagiline 49 OLEPTRO TM 49 MDD 49 Ampakine compounds 49 APTIVUS r 49 Campath 49 ® natalizumab 49 DARA BioSciences 49 Endo Pharmaceuticals ENDP 49 avanafil 49 Paliperidone Palmitate 49 Dainippon Sumitomo 49 oral calcitonin 49 CA9 SCAN 49 Synta Pharmaceuticals 49 ASCEND HF 49 Rituxan rituximab 49 MOZOBIL 49 acyclovir Lauriad R 49 tesmilifene 49 multitargeted 49 Viibryd 49 Daniel Junius 49 Tracleer 49 midstage trials 49 aripiprazole 49 Paladin Labs 49 VentiRx 49 tanezumab 49 NitroMist TM 48 anti TNF alpha 48 rALLy 48 INC# 48 tarenflurbil 48 Pegasys peginterferon alfa 2a 48 Rigel Pharmaceuticals Inc. 48 tramiprosate 48 linagliptin 48 Nexavar ® 48 RRMS patients 48 Peregrine Pharma 48 CYT#

Back to home page